Rubius Therapeutics Inc (OTC Pink - Limited Information:RUBY)

0.0218
Delayed Data
As of Jun 02
 +0.0007 / +3.32%
Today’s Change
0.01
Today|||52-Week Range
1.57
-87.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.0M

Company Description

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.

Contact Information

Rubius Therapeutics, Inc.
124 Washington Street
Foxboro Massachusetts 02035
P:(508) 543-1720
Investor Relations:

Employees

Shareholders

Individual stakeholders50.31%
Other institutional3.00%
Mutual fund holders0.73%

Top Executives

Craig R. JalbertPresident, Treasurer, Secretary & Director
James JogerstChief Business Officer
Lori MurrayChief Corporate Affairs Officer
Tamyra A. TooleVice President-Regulatory Affairs